IL45707A - Method of detecting antigens or antibodies - Google Patents

Method of detecting antigens or antibodies

Info

Publication number: IL45707A
Authority: IL; Israel
Prior art keywords: antigen; antibody; receptacles; receptacle; pair
Prior art date: 1973-10-26

Application number

IL45707A

Other languages

English (en)

Other versions

IL45707A0 (en

Original Assignee

Baxter Travenol Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1973-10-26

Filing date

1974-09-23

Publication date

1977-01-31

1974-09-23 Application filed by Baxter Travenol Lab filed Critical Baxter Travenol Lab

1974-11-29 Publication of IL45707A0 publication Critical patent/IL45707A0/xx

1977-01-31 Publication of IL45707A publication Critical patent/IL45707A/en

Links

239000000427 antigen Substances 0.000 title claims abstract description 82
102000036639 antigens Human genes 0.000 title claims abstract description 82
108091007433 antigens Proteins 0.000 title claims abstract description 82
238000000034 method Methods 0.000 title claims description 42
208000006454 hepatitis Diseases 0.000 claims description 20
231100000283 hepatitis Toxicity 0.000 claims description 19
239000013642 negative control Substances 0.000 claims description 10
102000004169 proteins and genes Human genes 0.000 claims description 9
108090000623 proteins and genes Proteins 0.000 claims description 9
230000005855 radiation Effects 0.000 claims description 6
-1 polyethylene Polymers 0.000 claims description 5
PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims description 4
239000002198 insoluble material Substances 0.000 claims description 4
239000000463 material Substances 0.000 claims description 4
230000002285 radioactive effect Effects 0.000 claims description 4
239000004793 Polystyrene Substances 0.000 claims description 3
239000011324 bead Substances 0.000 claims description 3
229920002223 polystyrene Polymers 0.000 claims description 3
NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 claims description 2
239000000020 Nitrocellulose Substances 0.000 claims description 2
239000004698 Polyethylene Substances 0.000 claims description 2
239000004743 Polypropylene Substances 0.000 claims description 2
229920001577 copolymer Polymers 0.000 claims description 2
239000011521 glass Substances 0.000 claims description 2
229920001220 nitrocellulos Polymers 0.000 claims description 2
229920000573 polyethylene Polymers 0.000 claims description 2
229920001155 polypropylene Polymers 0.000 claims description 2
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims 2
229910052740 iodine Inorganic materials 0.000 claims 2
239000011630 iodine Substances 0.000 claims 2
239000011248 coating agent Substances 0.000 claims 1
238000000576 coating method Methods 0.000 claims 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
239000007790 solid phase Substances 0.000 abstract description 22
238000010532 solid phase synthesis reaction Methods 0.000 abstract 1
238000003127 radioimmunoassay Methods 0.000 description 7
210000002966 serum Anatomy 0.000 description 6
239000000243 solution Substances 0.000 description 6
238000012360 testing method Methods 0.000 description 6
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 4
239000002245 particle Substances 0.000 description 4
239000002953 phosphate buffered saline Substances 0.000 description 4
239000000126 substance Substances 0.000 description 4
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
210000004369 blood Anatomy 0.000 description 3
239000008280 blood Substances 0.000 description 3
238000006243 chemical reaction Methods 0.000 description 3
238000011067 equilibration Methods 0.000 description 3
210000002381 plasma Anatomy 0.000 description 3
102000002260 Alkaline Phosphatase Human genes 0.000 description 2
108020004774 Alkaline Phosphatase Proteins 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
108010001336 Horseradish Peroxidase Proteins 0.000 description 2
238000003556 assay Methods 0.000 description 2
239000000872 buffer Substances 0.000 description 2
238000001514 detection method Methods 0.000 description 2
239000012857 radioactive material Substances 0.000 description 2
239000007787 solid Substances 0.000 description 2
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
238000004435 EPR spectroscopy Methods 0.000 description 1
PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
208000031220 Hemophilia Diseases 0.000 description 1
208000009292 Hemophilia A Diseases 0.000 description 1
241000700721 Hepatitis B virus Species 0.000 description 1
102000002265 Human Growth Hormone Human genes 0.000 description 1
108010000521 Human Growth Hormone Proteins 0.000 description 1
239000000854 Human Growth Hormone Substances 0.000 description 1
206010020751 Hypersensitivity Diseases 0.000 description 1
108060003951 Immunoglobulin Proteins 0.000 description 1
208000026935 allergic disease Diseases 0.000 description 1
230000007815 allergy Effects 0.000 description 1
230000000840 anti-viral effect Effects 0.000 description 1
238000010420 art technique Methods 0.000 description 1
229940098773 bovine serum albumin Drugs 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
230000000694 effects Effects 0.000 description 1
102000018358 immunoglobulin Human genes 0.000 description 1
229940072221 immunoglobulins Drugs 0.000 description 1
PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
239000007788 liquid Substances 0.000 description 1
239000003550 marker Substances 0.000 description 1
238000005259 measurement Methods 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
125000006501 nitrophenyl group Chemical group 0.000 description 1
239000005373 porous glass Substances 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
238000012216 screening Methods 0.000 description 1
238000001179 sorption measurement Methods 0.000 description 1
241000894007 species Species 0.000 description 1
239000000758 substrate Substances 0.000 description 1
238000010998 test method Methods 0.000 description 1
230000002747 voluntary effect Effects 0.000 description 1
238000005406 washing Methods 0.000 description 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/804—Radioisotope, e.g. radioimmunoassay
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/819—Multifunctional antigen or antibody
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/82—Hepatitis associated antigens and antibodies

Landscapes

Health & Medical Sciences (AREA)
Immunology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Medicinal Chemistry (AREA)
Analytical Chemistry (AREA)
Cell Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
Food Science & Technology (AREA)
Biotechnology (AREA)
Physics & Mathematics (AREA)
Microbiology (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Investigating Or Analysing Biological Materials (AREA)
Investigating Or Analyzing Materials By The Use Of Magnetic Means (AREA)

IL45707A 1973-10-26 1974-09-23 Method of detecting antigens or antibodies IL45707A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US05/410,066 US3949064A (en)	1973-10-26	1973-10-26	Method of detecting antigens or antibodies

Publications (2)

Publication Number	Publication Date
IL45707A0 IL45707A0 (en)	1974-11-29
IL45707A true IL45707A (en)	1977-01-31

Family

ID=23623067

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL45707A IL45707A (en)	1973-10-26	1974-09-23	Method of detecting antigens or antibodies

Country Status (15)

Country	Link
US (2)	US3949064A (fr)
JP (1)	JPS5762020B2 (fr)
AU (1)	AU476619B2 (fr)
BE (1)	BE820660A (fr)
BR (1)	BR7408886A (fr)
CA (1)	CA1036493A (fr)
DE (1)	DE2450523C3 (fr)
ES (1)	ES431413A1 (fr)
FR (1)	FR2249334B1 (fr)
GB (1)	GB1436934A (fr)
IL (1)	IL45707A (fr)
LU (1)	LU71027A1 (fr)
NL (1)	NL7413552A (fr)
SE (1)	SE7413484L (fr)
ZA (1)	ZA746098B (fr)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4172117A (en) *	1974-05-20	1979-10-23	Biotest-Serum-Institut Gmbh	Method for the simultaneous measurement of antigens and their antibodies by solid-phase radioimmunoassay
US4225784A (en) *	1976-06-17	1980-09-30	Smith Kline Instruments, Inc.	Covalently bound biological substances to plastic materials and use in radioassay
AT343822B (de) *	1976-08-20	1978-06-26	Immuno Ag	Radioimmunologisches verfahren und einrichtung zur bestimmung von antigenen
JPS604422B2 (ja) *	1976-10-07	1985-02-04	持田製薬株式会社	抗原の定量方法
USRE34394E (en) *	1978-01-23	1993-09-28	Baxter Diagnostics Inc.	Method and composition for double receptor, specific binding assays
JPS608745B2 (ja) *	1978-02-14	1985-03-05	三洋化成工業株式会社	免疫活性物質−つや消しガラス複合体，その製造法及び該複合体を含有してなる測定試薬
US4242322A (en) *	1978-06-07	1980-12-30	Electro-Nucleonics Laboratories, Inc.	Methods and materials for detecting antigens and antibodies
US4393040A (en) *	1981-03-24	1983-07-12	Lopapa Institute, Inc.	In-vitro diagnostic method for detection of acetylsalicylic acid ingestion
US4994373A (en)	1983-01-27	1991-02-19	Enzo Biochem, Inc.	Method and structures employing chemically-labelled polynucleotide probes
US5242798A (en) *	1983-07-21	1993-09-07	Scripps Clinic And Research Foundation	Synthetic polypeptides corresponding to portions of proteinoids translated from brain-specific mRNAs, receptors, methods and diagnostics using the same
EP0135277B1 (fr) *	1983-07-21	1986-10-29	Scripps Clinic And Research Foundation	Polypeptides synthétiques correspondant aux portions de protéinoides traduites de mARNs spécifiques au cerveau, récepteurs, méthode et diagnose utilisant ceux-ci
DE3586772T2 (de) *	1984-07-24	1993-03-04	Coselco Mimotopes Pty Ltd	Verfahren zur bestimmung von mimotopen.
US5182082A (en) *	1991-01-23	1993-01-26	Becton, Dickinson And Company	Multiple aliquot device for distributing a liquid solution into a well
US5877028A (en) *	1991-05-29	1999-03-02	Smithkline Diagnostics, Inc.	Immunochromatographic assay device
US5998220A (en) *	1991-05-29	1999-12-07	Beckman Coulter, Inc.	Opposable-element assay devices, kits, and methods employing them
US6168956B1 (en)	1991-05-29	2001-01-02	Beckman Coulter, Inc.	Multiple component chromatographic assay device
US5348867A (en) *	1991-11-15	1994-09-20	George Georgiou	Expression of proteins on bacterial surface
US5698686A (en) *	1994-10-20	1997-12-16	Arch Development Corporation	Yeast telomerase compositions
US5807552A (en) *	1995-08-04	1998-09-15	Board Of Regents, The University Of Texas System	Compositions for conferring immunogenicity to a substance and uses thereof
EP0854934A4 (fr) *	1995-08-18	2000-09-06	Donald W Landry	Detection de composes organiques par regulation de reactions catalysees par des anticorps
US6689757B1 (en)	1996-02-12	2004-02-10	M.L. Laboratories Plc	Methods for vaccination and vaccines therefor
US20020034732A1 (en) *	1997-07-30	2002-03-21	Daniel J. Capon	Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
US6610838B1 (en)	1997-09-10	2003-08-26	Symbicom Aktiebolag	P13 antigens from Borrelia
HK1044040A1 (zh)	1998-11-16	2002-10-04	德克萨斯州立大学董事会	Hiv-特异的t-细胞诱导
WO2002036777A1 (fr) *	2000-11-02	2002-05-10	The National University Of Singapore	Gene aopb, proteine, homologues, fragments et variants de celui-ci, ainsi que l'utilisation de ces derniers pour presentation a la surface cellulaire
US7847084B2 (en)	2002-12-20	2010-12-07	Board Of Regents, The University Of Texas System	VMP-like sequences of pathogenic Borrelia species and strains
WO2005035556A2 (fr) *	2003-05-06	2005-04-21	Iguazu Biosciences Corp.	Particules pseudo-virales du coronavirus du sras et methodes d'utilisation
CA2526690C (fr)	2003-05-23	2014-01-14	Board Of Regents The University Of Texas System	Oligonucleoside phosphorothioate selectionnes de maniere combinatoire et a base structurelle et facteurs de transcription ap-1 ciblant un phosphorodithioate aptamere
EP1998800A2 (fr)	2006-01-18	2008-12-10	University Of Chicago	Compositions et procédés se rapportant à des protéines de bactéries staphylococciques
NZ578657A (en) *	2007-02-02	2012-02-24	Baylor Res Inst	Multivariable antigens complexed with targeting humanized monoclonal antibody
TWI422594B (zh)	2007-02-02	2014-01-11	Baylor Res Inst	經由樹狀細胞去唾液酸糖蛋白受體（ｄｃ-ａｓｇｐｒ）接合抗原呈現細胞之藥劑
MX2009008140A (es)	2007-02-02	2009-10-26	Baylor Res Inst	Vacunas a base de antigeno dirigido a dcir expresado en celulas que presentan antigeno.
CN101679949B (zh)	2007-02-23	2015-08-19	贝勒研究院	通过dectin-1激活人抗原呈递细胞的治疗性应用
CA2717656A1 (fr) *	2007-02-23	2008-08-28	Baylor Research Institute	Activation de cellules humaines presentant un antigene par l'intermediaire de clec-6
EP2132226B1 (fr)	2007-02-23	2019-03-27	Baylor Research Institute	Activation de cellules humaines presentant un antigene par l'intermediaire du recepteur ldl 1 oxyde de type lectine (lox-1) de cellules dendritiques
WO2009059328A2 (fr) *	2007-11-02	2009-05-07	The Johns Hopkins University	Vaccin l2 multicomposant pour la prévention d'une infection de papillomavirus humain
KR20110036618A (ko)	2008-07-16	2011-04-07	베일러 리서치 인스티튜트	극대화된 Ｇａｇ 및 Ｎｅｆ를 수지상 세포에 표적화시킴을 기본으로 하는 ＨＩＶ 백신
WO2010042481A1 (fr)	2008-10-06	2010-04-15	University Of Chicago	Compositions et procédés associés aux protéines bactériennes eap, emp, et/ou adsa
EP3281947B1 (fr)	2009-04-03	2020-02-12	The University of Chicago	Compositions et procédés liés aux variantes de la protéine a (spa)
WO2011100508A2 (fr)	2010-02-12	2011-08-18	Arizona Board Of Regents For And On Behalf Of Arizona State University	Procédés et compositions liés à des fusions glycoprotéine-immunoglobuline
EP2555794A4 (fr)	2010-04-05	2014-01-15	Univ Chicago	COMPOSITIONS ET PROCÉDÉS LIÉS AUX ANTICORPS DE LA PROTÉINE A (SpA) EN TANT QUE AMPLIFICATEUR DE LA RÉPONSE IMMUNITAIRE
ES2655701T3 (es)	2010-07-02	2018-02-21	The University Of Chicago	Composiciones y métodos relacionados con variantes de la proteína A (SpA)
JP5793194B2 (ja)	2010-09-09	2015-10-14	ザ・ユニバーシティ・オブ・シカゴＴｈｅＵｎｉｖｅｒｓｉｔｙＯｆＣｈｉｃａｇｏ	感染防御ブドウ球菌抗原が関与する方法および組成物
WO2012058635A1 (fr)	2010-10-29	2012-05-03	Life Technologies Corporation	Dérivés de biotine
US8945588B2 (en)	2011-05-06	2015-02-03	The University Of Chicago	Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
HRP20201127T1 (hr)	2012-04-26	2020-11-27	University Of Chicago	Antigeni stafilokokne koagulaze i metode primjene istih
US9701719B2 (en)	2012-09-27	2017-07-11	Research Development Foundation	Attenuated Chikungunya virus
US10358667B2 (en)	2013-03-07	2019-07-23	University Of Maryland, Baltimore	Immunotherapeutic potential of modified lipooligosaccharides/lipid A
JP6836500B2 (ja)	2014-05-16	2021-03-03	ベイラーリサーチインスティテュートＢａｙｌｏｒＲｅｓｅａｒｃｈＩｎｓｔｉｔｕｔｅ	自己免疫状態および炎症状態を治療するための方法および組成物
US10662226B2 (en)	2016-10-28	2020-05-26	The Regents of the University of Caiifomia	Synthetic beta-amyloid peptides capable of forming stable antigenic oligomers
WO2019183500A1 (fr)	2018-03-23	2019-09-26	Hung Chiung Yu	Antigènes de coccidioides et leurs procédés d'utilisation
WO2020041360A1 (fr)	2018-08-21	2020-02-27	Quidel Corporation	Anticorps dbpa et leurs utilisations
EP3947454A1 (fr)	2019-03-27	2022-02-09	INSERM (Institut National de la Santé et de la Recherche Médicale)	Protéines recombinantes ayant des propriétés d'activation de cd40
AU2020273471B2 (en)	2019-05-14	2026-05-07	The University Of Chicago	Methods and compositions comprising Staphylococcus protein A (SpA) variants
JP2023502712A (ja)	2019-11-21	2023-01-25	インサーム（インスティテュナシオナルドゥラサンテエドゥラルシェルシェメディカル）	抗ｐｄ－１／ｉｌ－１５免疫サイトカインによる新しいｐｄ－１標的免疫療法
WO2021178637A1 (fr)	2020-03-05	2021-09-10	Iowa State University Research Foundation, Inc.	Compositions immunogènes et vaccinales dirigées contre le sars-cov-2
US20230183366A1 (en)	2020-05-13	2023-06-15	Inserm (Institut National De La Santé Et De La Recherch Médicale)	Recombinant proteins with ox40 activating properties
WO2023144779A1 (fr)	2022-01-28	2023-08-03	Pfizer Inc.	Variants d'antigène de coronavirus
WO2025017036A1 (fr)	2023-07-17	2025-01-23	Institut National de la Santé et de la Recherche Médicale	Échafaudages tubulaires hélicoïdaux alfavirus nsp3
WO2025027492A1 (fr)	2023-07-31	2025-02-06	Pfizer Inc.	Variants d'antigène de coronavirus
WO2025257397A1 (fr)	2024-06-14	2025-12-18	Institut National de la Santé et de la Recherche Médicale	Vaccins vivants atténués de bordetella capables de produire et de sécréter des antigènes hétérologues
WO2026022374A1 (fr)	2024-07-26	2026-01-29	Institut National de la Santé et de la Recherche Médicale	Méthodes de traitement prophylactique d'infections par le virus chikungunya

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE337223B (fr) *	1967-05-23	1971-08-02	Pharmacia Ab
SE343210B (fr) *	1967-12-20	1972-03-06	Pharmacia Ab
US3646346A (en) *	1968-12-26	1972-02-29	Pharmacia Ab	Antibody-coated tube system for radioimmunoassay
US3867517A (en) *	1971-12-21	1975-02-18	Abbott Lab	Direct radioimmunoassay for antigens and their antibodies

1973
- 1973-10-26 US US05/410,066 patent/US3949064A/en not_active Expired - Lifetime
1974
- 1974-09-23 IL IL45707A patent/IL45707A/en unknown
- 1974-09-25 ZA ZA00746098A patent/ZA746098B/xx unknown
- 1974-09-27 GB GB4199674A patent/GB1436934A/en not_active Expired
- 1974-09-28 JP JP49112223A patent/JPS5762020B2/ja not_active Expired
- 1974-09-30 AU AU73787/74A patent/AU476619B2/en not_active Expired
- 1974-09-30 CA CA210,357A patent/CA1036493A/fr not_active Expired
- 1974-10-01 LU LU71027A patent/LU71027A1/xx unknown
- 1974-10-03 BE BE149173A patent/BE820660A/fr unknown
- 1974-10-15 NL NL7413552A patent/NL7413552A/xx not_active Application Discontinuation
- 1974-10-15 FR FR7434561A patent/FR2249334B1/fr not_active Expired
- 1974-10-24 DE DE2450523A patent/DE2450523C3/de not_active Expired
- 1974-10-24 BR BR8886/74A patent/BR7408886A/pt unknown
- 1974-10-25 SE SE7413484A patent/SE7413484L/xx not_active Application Discontinuation
- 1974-10-26 ES ES431413A patent/ES431413A1/es not_active Expired
1978
- 1978-03-13 US US05/885,829 patent/USRE29955E/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
IL45707A0 (en)	1974-11-29
DE2450523C3 (de)	1978-06-22
USRE29955E (en)	1979-04-03
SE7413484L (fr)	1975-04-28
DE2450523B2 (de)	1976-10-07
BE820660A (fr)	1975-02-03
AU476619B2 (en)	1976-09-30
DE2450523A1 (de)	1975-05-22
LU71027A1 (fr)	1975-04-17
US3949064A (en)	1976-04-06
NL7413552A (nl)	1975-04-29
ES431413A1 (es)	1976-10-16
JPS5762020B2 (fr)	1982-12-27
BR7408886A (pt)	1976-05-04
JPS5075095A (fr)	1975-06-20
FR2249334A1 (fr)	1975-05-23
FR2249334B1 (fr)	1977-03-25
ZA746098B (en)	1975-11-26
CA1036493A (fr)	1978-08-15
GB1436934A (en)	1976-05-26
AU7378774A (en)	1976-04-01

Publication	Publication Date	Title
US3949064A (en)	1976-04-06	Method of detecting antigens or antibodies
US3966897A (en)	1976-06-29	Medium for use in bioassay and method of using same
US4242096A (en)	1980-12-30	Immunoassay for antigens
US4020151A (en)	1977-04-26	Method for quantitation of antigens or antibodies on a solid surface
EP0260965B1 (fr)	1992-11-11	Dispositif de diagnostic immunologique
US4851210A (en)	1989-07-25	Blood typing device
US4338094A (en)	1982-07-06	Macroencapsulated immunosorbent assay technique
EP0427984A1 (fr)	1991-05-22	Articles pour utilisation dans les techniques enzyme-immunoessais et méthodes pour fabriquer ces articles
EP0157797A1 (fr)	1985-10-16	Detection d'une reaction immunologique avec des globules rouges actives (erythrocytes)
EP0070300A1 (fr)	1983-01-26	Systeme en phase solide pour essai avec agent de liaison.
US4317810A (en)	1982-03-02	Waffle-like matrix for immunoassay and preparation thereof
US4865997A (en)	1989-09-12	Assay for ligands by separating bound and free tracer from sample
GB1564579A (en)	1980-04-10	Specific binding assay method ans test kit employing polyvinyl alcohol as separating agent
US4012494A (en)	1977-03-15	Direct radioimmunoassay for antigens and their antibodies
GB2199946A (en)	1988-07-20	Diagnostic device,
CA1340575C (fr)	1999-06-01	Article pour essais immunologiques utilisant des colorants organiques; methodes pour les produire et les utiliser
US4816413A (en)	1989-03-28	Solid phase indicator red blood cells and method
CA1336759C (fr)	1995-08-22	Mode de dosage d'une substance immunologiquement detectable et recipient approprie pour la reaction
JPH02140147A (ja)	1990-05-29	赤血球から血漿を分離する方法および装置
JPS5915861A (ja)	1984-01-26	免疫分析用材料
GB1597556A (en)	1981-09-09	Device for use in immunoassays
WO1990015328A1 (fr)	1990-12-13	Essai immunitaire ameliore
JP2570408B2 (ja)	1997-01-08	抗原，抗体又は生理活性物質固定化用の担体
JPS6017358A (ja)	1985-01-29	分析容器
JPS6318704B2 (fr)	1988-04-19